We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Proactis Holdings Plc | LSE:PHD | London | Ordinary Share | GB00B13GSS58 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 74.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
11/6/2021 15:05 | Thanks cure, you too bud. Take care. | coldspring | |
11/6/2021 09:54 | Would love to see a gate-crasher jump in. Highly unlikely but not impossible. | p1nkfish | |
11/6/2021 09:06 | Good luck Cure. | p1nkfish | |
11/6/2021 08:46 | Well that’s it for me guys, I’m out. Was hoping DBAY would give us another 10% but wasn’t to be. No complaints though as a healthy profit made. Thanks to all the regular posters here for keeping things interesting especially p1nk and cold spring with your informative comments. I’ve put some profit into PHE for the long haul. It’s been a decent start there. All the best and cheers! | cureboy | |
11/6/2021 08:03 | Wonder if they will try to get it through extra quickly? | p1nkfish | |
11/6/2021 07:11 | It is done, 75p, different split with DBAY, should complete before end of Oct 2021. Expect it to be sooner than that. TU Aug and EOY report? | p1nkfish | |
10/6/2021 18:11 | Tomorrow morning then or else a complaint go the panel as this is not acceptable. | p1nkfish | |
10/6/2021 16:21 | "by" doesn't mean the same to these people as it does to the rest of us. shambles. "must be" doesn't mean much too. | p1nkfish | |
10/6/2021 10:56 | Interesting Cure. Would like to be listening into the dialogue between all the parties, probably not been a very easy negotiation and guess they are now wording something for release. | p1nkfish | |
10/6/2021 10:21 | Poster over on LSE noted DBAY sold out of their position in Dialight last week. Coincidental timing? DBAY need to act soon here, I expect announcement of a move to offer. | cureboy | |
10/6/2021 09:36 | "the date by which" is 11th June. Perhaps that includes 11th but I read it as "by" so good chance of info today. "Bidco and Proactis have agreed to extend the date by which the Scheme Document must be posted to Proactis Shareholders to 11 June 2021." | p1nkfish | |
09/6/2021 17:22 | Not as sharp as we might think. | p1nkfish | |
09/6/2021 17:11 | Clock is ticking DBAY... | cureboy | |
05/6/2021 23:30 | Always the chance an extra 10% arrives. | p1nkfish | |
05/6/2021 06:29 | By end Friday 11th we should know and gap to 75p might well have closed a little more. | p1nkfish | |
04/6/2021 23:06 | There's a chance DBAY will be asked to support at 75p and offered chance to participate in a future funding round after the business is fully assessed, expected to take 6 months post completion. Support & participate. | p1nkfish | |
03/6/2021 09:13 | Very interested to see the next TU and forward look. If the TU is not decent, and the sale of the company falls through (unlikely imho), then someone will acquire this at < 75p and it won't be Pollen or DBAY. Both will be totally shafted as will the company. | p1nkfish | |
02/6/2021 18:19 | No chance Cure, I think they are old hands at this and will leverage their 25%+ to the very end. Both meeting in no mans' land to discuss before returning to their trenches to decide what next. Best thing Pollen could do is go to Offer, however, going to offer might force DBAY to go to 10% extra and if Pollen won't stretch to that DBAY win. Both want to maximise outcome at little extra cost. | p1nkfish | |
02/6/2021 17:45 | Really wish DBAY would show their hand or FO. | cureboy | |
01/6/2021 23:56 | Still a chance of a 3rd interested party. Watching and waiting. | p1nkfish | |
31/5/2021 10:06 | What is really on the table is the extra 7.1M DBAY may have to cough-up to buy PHD if they are unhappy but don't want to trash the value of their holding and damage the company too. On top is Lombardier that are unlikely to accept < 75p cash from any other offeror now and hold nearly 30%. Worth a punt imho. Take care, dyor etc. Check the figures, just in case. | p1nkfish | |
31/5/2021 10:00 | So we can expect news, good or bad, by end 11th June. Just to re-iterate, if Pollen want PHD, and DBAY don't support and participate, what happens? Pollen move to offer. If DBAY want PHD they have to offer 10% over 75p to break the irrevocables, Pollen may walk hence Pollen stick to talking if they have a firm line in the sand on price to be paid. What is there between these outcomes if Pollen/DBAY want PHD? If Pollen walk they can't come back for a while, price falls. DBAY can pick up more stock cheaply to 30% (about another 5%) but no more without making an offer that must be at least their most recent highest price paid (for a while at least). This could all collapse but DBAY would hurt too as price would fall. Pollen could walk with some money now spent but move on intact. PHD would carry on but probably having to make changes - possibly substantial and impacting future value - short term not good. DYOR - Its a gamble but the CAGR on a buy now could be the 4p upside (71p buy price) in < 3 months. 4x 4/71 = 22%. If DBAY come in with 10% more its about >50% CAGR on a 71p buy price. "The extension has been agreed to facilitate ongoing discussions between Bidco and DBay Advisors Limited ("DBay") regarding DBay's support for, and participation in, the Acquisition at an offer price of 75 pence in cash for each Proactis Share." | p1nkfish | |
29/5/2021 20:13 | I have bought a few times, less volume than in the past when lower priced but just to finish off getting something out of this. There are outcome scenarios that are less than ideal but worth the risk of a punt for me. | p1nkfish |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions